Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of NVZMY will - over the next 2 Weeks and hit - by . In that time frame, NVZMY's share price is expected to range between - and -.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
No Data | |||||||||||||||||||
NVZMY shares fell -0.43% in Monday, July 20, 2026's trading session, dropping from a previous close of $64.82 to move at $64.54. The stock demonstrated notable intraday movement (see NVZMY's key stats for a full breakdown), fluctuating between $64.19 and $64.77, a +0.90% trading range. While recent weeks have seen some volatility, NVZMY has managed to secure a -1.22% drop over the past 2 weeks. The downward price movement was accompanied by increased trading volume, with approximately 39.82K shares changing hands, 13.11K more than the previous session. This amounted to $2.57M in total market activity.
Will NVZMY Continue Its Trend?
According to analyst ratings and projections for NVZMY, Novozymes A/S shares are anticipated to remain stable by -, potentially reaching - per share by January 1, 1970. Short-term technical indicators currently suggest a bearish sentiment for NVZMY. However, the stock has recorded 16 positive trading days within the past 30 sessions. Based on the NVZMY stock forecast, now is not the best time to buy NVZMY stock because its current trading price is - our predicted value, hinting at a possible . For deeper insights, view our sentiment analysis on NVZMY covering social and institutional perspectives.
NVZMY Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into NVZMY's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 55.97% to 58.57%) suggest the stock is in a neutral to slightly bearish momentum phase. The 50-day RSI, at 55.12%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 52.36%, maintains a neutral outlook for the long term. Insights into NVZMY's shareholder base show how institutional investors are positioning themselves during these momentum shifts

